|
Aigner A, Butscheid M, Kunkel P, Krause E,
Lamszus K, Wellstein A, Czubayko F.
An FGF-binding protein (FGF-BP) exerts its biological
function by parallel paracrine stimulation of tumor cell and
endothelial cell proliferation through FGF-2 release.
Int J Cancer 92
(2001) 510-519
Aigner A, Juhl H, Malerczyk C, Thybusch A,
Benz C C, Czubayko F.
Expression of a truncated 100 kDa HER2 splice variant
acts as an endogenous inhibitor of tumour cell proliferation.
Oncogene 20
(2001) 2101-2111
Baumann F, Preiss R:
Review, Cyclophosphamide and related anticancer drugs.
J Chromatogr B 764 (2001) 173-192.
Fiedler R, Baumann F, Deschler B, Osten B:
Haemoperfusion combined with haemodialysis in ifosfamide intoxication.
Nephrol Dial Transplant 16 (2001) 1088-1089.
Fischer W, Kittner H, Regenthal R,
Malinowska B,
Schlicker E:
Anticonvulsant and sodium channel blocking activity of higher doses of
clenbuterol.
Naunyn-Schmiedeberg´s Arch Pharmacol 363
(2001) 182-192.
Franke H, Krügel U, Schmidt R,
Grosche J,
Reichenbach A, Illes P:
P2-receptor-types involved in astrogliosis in vivo.
Brit J Pharmacol 134 (2001) 1180-1189.
Kaup B, Schindler I, Knüpfer H,
Schlenzka A,
Preiss R, Knüpfer MM:
Time-dependent inhibition of glioblastoma cell proliferation by
dexamethasone.
J Neuro Oncol 51 (2001) 105-110.
Knüpfer H, Stanitz D, Brauckhoff M,
Schmidt R,
Knüpfer MM, Preiss R:
IL-1 receptor type I expression in breast cancer.
Breast 10 (2001) 411-415.
Knüpfer MM, Pulzer F, Schindler I,
Hernaiz-Driever P, Knüpfer H, Keller E:
Different effects of valproic acid on proliferation and migration of
malignant glioma cells in vitro.
Anticancer Res 21 (2001) 347-352.
Krüger M, Aschenbach H, Terhaag B,
Haase H,
Richter K, Oertel R, Preiss R:
Pharmacokinetics of oral talinolol following a single dose and during
steady state in patients with chronic renal failure and healthy
volunteers.
Int J Clin Pharmacol Ther 39/2 (2001) 61-66.
Liu-X-H, Aigner A, Wellstein A, Ray P E.
Up-regulation of a fibroblast growth factor binding
protein in children with renal diseases.
Kidney Int 59
(2001) 1717-1728
Poelchen W, Kittner H, Sieler D, Regenthal
R,
Preiss R,
Illes P:
In vitro tolerance to inhibition by ethanol of
N-methy-D-aspartate-induced depolarization in locus coeruleus neurons
of behabiorally ethanol-tolerant rats.
Neurochem Int 39 (2001) 51-58.
Schmidt R, Baumann F, Hanschmann H, Geissler
F, Preiss R:
Gender differences in ifosfamide metabolism by human liver microsomes.
Eur J Drug Metab Ph 26 (2001) 193-200.
Stoica G E, Kuo A, Aigner A, Sunitha I,
Souttou B, Malerczyk C, Caughey D J, Wen D, Karavanov A, Riegel A T,
Wellstein A.
Identification of anaplastic lymphoma kinase as a
receptor for the growth factor pleiotrophin.
J Biol Chem 276(20)
(2001) 16772-16779
Stöppler H, Malerczyk C, Block K, Aigner A, Czubayko F.
The human papillomavirus (HPV) 16 E6 oncoprotein leads to an
increase in gene expression of the angiogenic switch molecule FGF-BP in
non-immortalized human keratinocytes.
Oncogene 20 (2001) 7430-7436
Tassi E, Al-Attar A, Aigner A, Swift M R,
McDonnell K, Karavanov A, Wellstein A.
Enhancement of fibroblast growth factor (FGF) activity
by an FGF-binding protein.
J Biol Chem 276(43)
(2001) 40247-40253
Thybusch-Bernhardt A, Aigner A, Beckmann S,
Czubayko F, Juhl H.
Ribozyme targeting of HER-2 inhibits pancreatic cancer
cell growth in vivo.
Eur J Cancer 37
(2001) 1688-1694
Zugmaier G, Aigner A, Knabbe C, Neubauer A,
Jäger R.
Differential secretion of paracrine heparin-binding growth factors by
small-cell and non-small-cell lung cancer cell lines.
Res Adv Cancer 1
(2001) 11-13 R M Mohan (Ed), Global Research Network, Trivandrum
|